US-based seed tech company InnerPlant says it has reached an important regulatory milestone with the completion of the FDA’s New Protein Consultation (NPC) process for the fluorescent protein used in its InnerSoy product.
Shely Aronov, CEO and cofounder of InnerPlant, highlighted the process as “a meaningful step forward in our regulatory pathway providing support for the safety of our science.”
InnerPlant genetically engineers plants so that they signal distress via fluorescent proteins when under attack from disease, pests, or other environmental threats. In other words, these “sensor plants” turn fluorescent colors the company says can be seen from as far away as space.
The InnerSoy product signals fungal pressure in soybean plants by emitting the fluorescent signal at the earliest signs of fungal stress.
It’s this product that just completed the FDA consultation, which evaluates “non-pesticidal protein produced by the new plant variety under the development of food for use.”
The post InnerPlant takes ‘meaningful step’ in regulatory journey for genetically engineered ‘sensor plants’ appeared first on AgFunderNews.